Inventor
Chikateru Nozaki
Inventor
Kumamoto, JP
Overview
Patents· 33 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
C12NMicroorganisms or enzymes20%
C07KPeptides19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
C07HSugars4%
C12YEnzymes3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
PatentTitleYear
10,556,005Adjuvant composition containing citrulline20209,381,242'Adjuvant composition containing citrulline'20169,114,098'Method for using inactivated Japanese encephalitis virus particles as adjuvant'20159,028,463'Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device'20158,940,306'Method for enhancing immune response with peptide'20158,883,165'Modified peptide vaccine derived from influenza M2'20148,853,354'Polyion complex comprising hydrophobized polyamino acid and use of the same'20148,623,374'Method for enhancing immune response with peptide'20148,512,709'Modified amyloid β peptide'20138,106,015'Method for enhancing immune response with peptide'20128,067,221'Von Willebrand factor (vWF)-cleaving protease'20118,043,629'Bioabsorbable synthetic nonwoven fabric holding thrombin'20117,960,508'Peptide having cytotoxicity inhibitory activity and method of screening these peptide having cytotoxicity inhibitory activity'20117,704,951'Method for ameliorating dyskinesia'20107,635,577'Process for producing human thrombin by gene modification technique'20097,598,349'Antibodies to peptide fragments having cell death-inhibitory activity'20097,575,872'Antibody against von Willebrand factor cleaving enzyme and assay system using the same'20097,361,748'von Willebrand factor (vWF)—cleaving protease'20087,199,097'Peptide fragments having cell death inhibitory activity'20077,112,666'Von Willebrand Factor (Vwf)-cleaving protease'20066,995,146'Compositions and methods for treatment of hepatitis C virus-associated diseases'20066,608,191'Compositions and methods for treatment of hepatitis C virus-associated diseases'20036,423,489'Compositions and methods for treatment of Hepatitis C virus-associated diseases'20026,391,542'Compositions and methods for treatment of Hepatitis C virus-associated diseases'20026,284,458'Compositions and methods for treatment of hepatitis C virus-associated diseases'20016,174,868'Compositions and methods for treatment of hepatitis C virus-associated diseases'20015,811,260'Exogenous gene expression vector containing chick .beta.-actin gene promoter'19985,770,400'Exogenous gene expression vector containing chick .beta.-actin gene promoter'19985,059,538'Recombinant plasmid inserted with herpes simplex virus gene'19915,024,938'Recombinant DNA inserted with hepatitis B virus gene, mammalian cells transformed with cloned viral DNA, and production of hepatitis B virus proteins'19914,997,767'Yeast shuttle vector'19914,778,761'Recombinant plasmid inserted with hepatitis B virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis B virus surface antigen'19884,612,283'Method for purification of HBs antigen'1986Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1986–2015Patents assigned to CHEMO SERO THERAPEUT RES INST (24)· patent assignee history
1986–2020Based in Kumamoto, JP· patent location history
2001–2006Patents assigned to ISIS PHARMACEUTICALS INC (6)· patent assignee history
2006–2015Based in Kikuchi-gun, JP· patent location history
2006Based in Kumanoto, JP· patent location history
2011–2016Patents assigned to NOZAKI CHIKATERU (9)· patent assignee history
2012–2016Patents assigned to KAMINAKA KAZUYOSHI (8)· patent assignee history
2012–2016Patents assigned to MATSUDA JUNICHI (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHEMO SERO THERAPEUT RES INST | 24 | 1986–2015 |
| NOZAKI CHIKATERUself | 9 | 2011–2016 |
| KAMINAKA KAZUYOSHI | 8 | 2012–2016 |
| MATSUDA JUNICHI | 7 | 2012–2016 |
| ISIS PHARMACEUTICALS INC | 6 | 2001–2006 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kumamoto, JP | 20 | 1986–2020 |
| Kikuchi-gun, JP | 12 | 2006–2015 |
| Kumanoto, JP | 1 | 2006 |